Safer Medicines Trust publishes an evaluation of the UK’s Early Access to Medicines Scheme
Our paper on the UK’s Early Access to Medicines Scheme has just been published. We found that many drugs expedited as part of the scheme do not have an established safety profile, while several appear to have significant risks for patients. We argue that the Medicines and Healthcare products Regulatory Agency needs to insist on more robust evidence before fast tracking drugs, and that among other things, the safety of expedited drugs might be improved with greater preclinical use of human biology-based technologies.
Read the paper here: https://lnkd.in/dHSi4FkZ Safer Medicines Trust
Read the paper here: https://lnkd.in/dHSi4FkZ
Safer Medicines Trust